Medrio Partners wWth Adaptive Clinical Systems To Broaden eClinical Integration Offerings

Thursday, September 20, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

To meet their complex integration needs, organizations conducting clinical trials now have more options to enable interoperability.

SAN FRANCISCO, September 20, 2018 /PRNewswire-PRWeb/ -- Medrio, an eClinical software as a service (SaaS) company providing

cloud-based EDC, eSource, and ePRO tools for clinical trials, has partnered with Adaptive Clinical Systems, a provider of cloud-hosted services that offer true interoperability, to further expand integration options between the Medrio platform and other eClinical systems. Organizations can now integrate Medrio's solutions with a wide array of systems through Adaptive ClinicalŪ's validated iPaaS (interoperability Platform as a Service) Adaptive eClinical BusŪ, as well as through Medrio's existing proprietary APIs. The resulting interoperability accelerates clinical processes through the elimination of manual data transfer between systems and reduced study timelines.

The partnership creates more flexibility for Medrio users looking to transfer data between systems. The Adaptive eClinical BusŪ enables any organization, including those with limited infrastructure, to seamlessly integrate Medrio EDC and eSource with a third-party CTMS, medical imaging system, or other eClinical solution. "The Adaptive eClinical BusŪ broadens our integration offerings to our customers," commented Fred Martin, Vice President of Product and Engineering at Medrio. "Our native APIs have already served a diverse array of integration needs in clinical trials of all types. Thanks to our new partnership, organizations are better able to take the approach to integration most aligned with their needs, priorities, and capabilities."

"Early Phase studies are critical to the success of any novel drug's introduction," added Sina Adibi, CEO and President of Adaptive Clinical Systems. "By enhancing the power of Medrio's EDC, ePRO and eSource through increased interoperability, we are excited to enable our clients to further accelerate and improve the quality of their data collection during those critical studies."

Software integration has become an essential capability in clinical research. With a single clinical trial today often utilizing a multitude of eClinical systems, organizations that use manual double data entry to transfer data between systems make their data increasingly vulnerable to transcription error and put their studies at risk of delay. By automating this process, integration enables organizations to better ensure data quality and keep study timelines down.

About Medrio Medrio is a leading healthcare technology company providing eClinical solutions including EDC, eSource, and ePRO for clinical research. Founded in 2005, the company's cloud-based software platform and mobile suite of products deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient reported outcome responses. Study sponsors and contract research organizations have used Medrio extensively across drug, device, diagnostic, and animal health trials.

Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 500 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit

About Adaptive Clinical Systems Adaptive Clinical Systems offers a simple, secure, validated, compliant, and cost-effective solution for clinical data integration. For organizations struggling with integration of clinical study data from multiple systems and platforms, the Adaptive eClinical Bus, a cloud-based hosted service, will integrate with any EDC, eCOA, CTMS, Medical Imaging, IRT, analytical/data visualization and other systems to ensure accurate and efficient transfer of clinical data for any study of any complexity. Please visit



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store